Keith Skubitz

Professor of Medicine, Division of Hematology, Oncology and Transplantation


Administrator Info
Name: Linsey Roschen
Fax: 612-625-6919
Mail: 420 Delaware ST SE, MMC 480, Minneapolis, MN 55455

Dr. Skubitz has led the medical oncology arm of the Bone and Soft Tissue Tumor program at the University since 1988. He received an AB in physics and chemistry from Cornell University and an MD from the Johns Hopkins University School of Medicine, and then did internal medicine training at the University of Minnesota. He completed two fellowships, one in Clinical Pharmacology at Johns Hopkins and one in Medical Oncology at the University of Minnesota.

Research Summary

Dr. Skubitz cares for patients with a variety of malignancies and related diseases. His research primarily involves drug development and clinical trials, including the use of genomics to identify new drug targets and predict disease outcome.

Clinical Summary

Variety of malignancies and related diseases including sarcomas and kidney cancer; Bone and soft tissue cancer


MD, Johns Hopkins University School of Medicine

Honors and Recognition

University Innovation Award, University of Minnesota, Department of Medicine
Top 1% of Most-Cited Investigators in Biosciences
International Who's Who of Professionals (1996-present)
Phi Kappa Phi
Inventor Recognition Award, University of Minnesota (2005, 2008, 2017)

Professional Memberships

American College of Physicians
Johns Hopkins Medical and Surgical Society
American Federation for Clinical Research
American Association for Cancer Research
American Society for Cell Biology
New York Academy of Sciences
Central Society for Clinical Research
Minneapolis Society of Internal Medicine
American Society of Clinical Oncology
International Society of Hematology
Society for Leukocyte Biology
Connective Tissue Oncology Society
University of Minnesota Sarcoma Executive Committee
American Society of Hematology, Member
American Association for the Advancement of Science, Member
Medical Oncology Arm of the Bone and Soft Tissue Tumor Program, Head